VLP Therapeutics (Series A-1)

Funding Details
Awarder
Inbox
Date Award
December 28, 2021
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$21,000,000

Company Info
Founding Year
2013
Founders
Wataru Akahata, Ryuji Ueno, Sachiko Kuno
Company Description
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Market
Vaccine Development
Location
Gaithersburg, MD, USA
Coinvestors
Miyako Capital, MUFG Bank, Nobelpharma Co., Robert G. Hisaoka, SK Impact Fund, Sojitz Corporation

Links